A detailed history of Swedbank Ab transactions in Abb Vie Inc. stock. As of the latest transaction made, Swedbank Ab holds 2,147,126 shares of ABBV stock, worth $437 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
2,147,126
Previous 2,140,316 0.32%
Holding current value
$437 Million
Previous $367 Million 15.5%
% of portfolio
0.55%
Previous 0.5%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $1.12 Million - $1.36 Million
6,810 Added 0.32%
2,147,126 $424 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $331 Million - $387 Million
2,140,316 New
2,140,316 $367 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $322 Million - $367 Million
2,017,416 New
2,017,416 $367 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.